Canopy USA

Canopy Is 'Cautiously Optimistic' On Cannabis Rescheduling Following Major Step Toward Entry Into US THC Market
Canopy Growth Reports 7% YoY Drop In Q3 Revenue, CEO Touts 'New Era' For Company As It Seeks US Listing
Acreage Further Streamlines Board Of Directors
Canopy Growth Reports 7% YoY Drop In Q3 Revenue, CEO Touts 'New Era' For Company As It Seeks US Listing
Acreage Further Streamlines Board Of Directors
Acreage Q1 Revenue Declines 1.6% YoY, What About Adjusted EBITDA?
Acreage FY22 Revenue Grows 26% To $237.1M

Canopy USA Recent News

Cannabis MSOs Are Refinancing At Higher Costs, Check Their Balance Sheets Analyst Advises
Even top multi-state operators (MSOs) are feeling the impact of the demand  and supply capital imbalance faced by the cannabis industry, says Cantor Fitzgerald's Pablo Zuanic who noted that refinancings are being undertaken at higher than normal costs.
Canopy USA Increases Conditional Ownership Of TerrAscend By Converting $91.8M Of Debt To Exchangeable Shares
TerrAscend Corp.
Canopy Growth Q2 2023 Revenue Grows 7% Sequentially, Another Record Quarter For BioSteel
Canopy Growth Corporation (NASDAQ: CGC) (TSX:WEED) Q2 FY2023 net revenue was CA$118 million ($87.8 million), a 10% decrease compared to Q2 FY2022.
Acreage Holdings Q3 Financial Results, A "Highly Attractive Positioning"
Acreage Holdings, Inc.(CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF), reported its financial results late Monday for the third quarter ended September 30, 2022 (“Q3 2022”).
What Happens To Cannabis Bills If Republicans Take House And Senate? Here's One View
"The Risk of a Post-Election Funk”
Canopy Growth Transfers Its TerrAscend Assets To Canopy USA Company
Canopy Growth Corporation (NASDAQ: CGC) (TSX:WEED) and Canopy USA, LLC announced that each of the company and Canopy USA has filed an early warning report under National Instrument 62-103 - The early warning system and related take-over bid